Company profilePharmaceutical#117 of 1,318 in Pakistan✓ No DRAP alerts

P.D.H. PHARMACEUTICALS (PVT) LTD.

Pharmaceutical company · 138 brands · 182 molecules

Ranked #19 of 50 companies in Anti-Infective, Ophthalmologicals

138 registered products 46 pharmaceutical brands 182 distinct molecules 0 DRAP alerts

Company overview

138
registered products
46
pharmaceutical brands
182
distinct molecules
12
therapeutic classes
0
DRAP alerts

P.D.H. PHARMACEUTICALS (PVT) LTD. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 138 product registrations across 182 distinct molecules. It is the 117th largest registrant in Pakistan by product count, and ranks 19th of 50 in Anti-Infective, Ophthalmologicals. Its portfolio is concentrated in Anti-Infective, Ophthalmologicals and Lipid Modifying Agents. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by P.D.H.

86 products matched in our catalogue · showing 80 — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

83
ceilings with an approval date
3
not revised in 2+ years
2024
oldest approval year
20243
202524
202656
Longest without revision

Top molecules by brand count

Risperidone5 brands
Pyridoxine5 brands
Sodium Acid5 brands
Eye5 brands
Thiamine4 brands
Simvastatin4 brands
Linezolid4 brands
Enalapril4 brands
Diclofenac3 brands

Therapeutic classes

Anti-Infective, Ophthalmologicals · 3Lipid Modifying Agents · 2Beta-Lactam Antibacterials, Penicillins · 2Antiinflammatory And Antirheumatic Products · 2Opioids · 2Drugs For Obstructive Airway Diseases, Systemic · 2Antihistamines For Systemic Use · 2Other Beta-Lactam, Cephalosporins & Penems · 2Antidiarrheals, Intestinal Antiinflammatory/Antiinfective · 1Cardiac Care · 1Angiotensin-Ii Antagonists, Combinations · 1Vitamin B1, & Combinations Of B1, B6, B12 · 1

Conditions treated

Hypertension · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official109 products · Rs 1.98 – Rs 7,470.05
DVAGO1 products · Rs 250 – Rs 250
Servaid1 products · Rs 320 – Rs 320
Median across source: Rs 250

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

ZAFA PHARMACEUTICAL LABORATORIES (PVT) LTD. holds 122 molecules not in this portfolio
AlbuterolAminophyllineAmlodipineAmlodipine BaseAmmonium ChlorideAmmonium Chloride Containing Expectorants
Wilshire Laboratories (Private) Limited holds 108 molecules not in this portfolio
AcyclovirAcyclovir SodiumAlfacalcidolAmlodipineAnastrozoleArtemether
Atco Pharma International (Pvt) Ltd holds 210 molecules not in this portfolio
Acetylsalicylic AcidAcyclovirAdapaleneAdapleneAlbuterolAminophylline

Get the full profile for P.D.H.

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.